Medical comms - Press Releases

Date	Title	Company
07-Jan-2021	Rinri Therapeutics Appoints Terri Gaskell, PhD as Chief Technology Officer	Rinri Therapeutics
07-Jan-2021	Global Closed MRI Systems Market Comprehensive Study Explores Huge Growth in Future \| Healthcare Industry \| GE Healthcare, Philips Healthcare, Siemens Healthcare	Marketresearch.biz
06-Jan-2021	New Executive Board Role at Synergy Vision as Growth Drives Transition from Small to Medium-Sized Enterprise	Synergy Vision
04-Jan-2021	Stefan Przyborski from University of Durham invites you to join 3D Cell Culture Virtual Conference	SMi Group
23-Dec-2020	MaxCyte to exceed 2020 Full Year market expectations	MaxCyte
23-Dec-2020	Amryt Granted Orphan Drug Designation by the FDA for AP103	Amryt
23-Dec-2020	Novadip Biosciences Receives Rare Paediatric Disease Priority Review and Orphan Disease Designation	Novadip Biosciences
23-Dec-2020	CURRANZ AWARDED TWO ACCOLADES AT THE EUROPEAN SPECIALIST SPORTS NUTRITION ALLIANCE AWARDS 2020	CurraNZ
23-Dec-2020	UPM Biochemicals grows lignin business with new Domtar supply agreement	UPM Biochemicals
22-Dec-2020	VFMCRP and ChemoCentryx provide topline results from ACCOLADE trial of avacopan in C3 glomerulopathy including improved estimated glomerular filtration rate (eGFR)	Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
22-Dec-2020	Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study	Bone Therapeutics
22-Dec-2020	Chi-Med to Present at the 39th Annual JP Morgan Healthcare Conference	Chi-Med
22-Dec-2020	Update on the recently acquired NTCD-M3 biotherapeutic clinical programme for prevention of recurrence of C. difficile infections	Destiny Pharma plc
22-Dec-2020	GLOBAL TEAM OF SCIENTISTS UNITE TO ASSESS ROLE OF T CELLS IN THE BATTLE AGAINST COVID-19 AND EVALUATE STEPS IN MANAGING AND PROTECTING AGAINST FUTURE INFECTIOUS DISEASE	Global T cell Expert Consortium
22-Dec-2020	54% of UK healthcare professionals say factors other than patients’ best interests influence their medical decision-making	JMW’s Clinical Negligence team
22-Dec-2020	Polyphor receives approval to start first-in-human clinical trial of inhaled antibiotic murepavadin	Polyphor
22-Dec-2020	Bone Therapeutics finalise le recrutement et le traitement des patients dans son étude pivot de Phase III évaluant le JTA-004 dans l’arthrose du genou	Bone Therapeutics
22-Dec-2020	VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)	Vifor Pharma Group
22-Dec-2020	UKCPA Meets Demand For Critical Care Training With New Online	The UK Clinical Pharmacy Association (UKCPA)
22-Dec-2020	Transgene and BioInvent receive CTA approval for Phase 1/2a trial of oncolytic virus BT-001 in solid tumors	Transgene